
Philogen
Sovicille, Italy philogen.com From their website, Nov 2026
- GMP
- ISO 9001
Work here? Claim this listing
About
Philogen is a Swiss-Italian biotechnology company founded in 1996 that discovers, manufactures, and develops targeted drugs for cancer and other serious conditions. It operates from sites in Italy and Switzerland and runs work from discovery through clinical development.
Services
Target discovery
Identifies accessible disease targets and discovers antibodies and small organic ligands.
Ligand screening through discovery collaborations
Offers flexible collaboration structures for screening binders against one or multiple targets using proprietary discovery platforms.
DNA-encoded library discovery
Uses DNA-encoded chemical libraries for fast and cost-effective drug discovery.
Antibody discovery
Uses antibody phage libraries to isolate fully human monoclonal antibodies against antigens of interest.
Cyclic peptide discovery
Uses proprietary phage libraries of short cyclic peptides for screening and binder isolation.
Prototype development
Couples targeting ligands with bioactive payloads to generate targeted drug candidates.
Preclinical evaluation
Tests targeted drugs in preclinical models.
ADME, DMPK & toxicology
Cell line development
Provides customized activities for cell line development in collaboration settings.
Cell line development
10 more services
- GMP manufacturing
- Manufacturing collaborations
- Clinical trial management
- Bioanalytics
- Preclinical development
- Clinical development
- Discovery collaborations
- DNA-encoded library screening
- R&D discovery
- Clinical trials
Capabilities
- Processes
- Small molecule
- Antibody
- Peptide
- Cell therapy
- Recombinant protein
- Bioanalysis
- Capacity
- More than one billion compounds
- More than 100 billion members
- Two GMP manufacturing facilities near Siena
- Up to Phase III clinical trials
- 21 clinical trials
- More than one billion compounds in DNA-encoded chemical libraries
- More than 100 billion members in antibody phage libraries
- More than 100 billion members in short cyclic peptide phage libraries
Equipment
- DNA-encoded chemical libraries
- Antibody phage libraries
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
GLPSelf-reported
ISO 9001:2015Self-reported
Industries served
- Biotech
- Pharmaceuticals
- Oncology
Details
- Type
- CRDMO
- Founded
- 1996
- Based in
- Sovicille, Italy
- Sites
- Siena, Italy
- Monteriggioni (SI), Italy
- Milano, Italy
- Otelfingen, Switzerland
- Monteriggioni, Italy
- Zürich, Switzerland
- Phone
- (+39) 0577.1781.6